DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,032 | -79.4% | 97 | -79.0% | 0.00% | – |
| Q3 2022 | $5,000 | – | 462 | +9140.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 5 | -99.9% | 0.00% | -100.0% |
| Q3 2021 | $102,000 | +137.2% | 5,324 | +21.6% | 0.01% | +150.0% |
| Q2 2021 | $43,000 | +4200.0% | 4,379 | +6339.7% | 0.00% | – |
| Q1 2021 | $1,000 | -97.9% | 68 | -98.7% | 0.00% | -100.0% |
| Q2 2020 | $47,000 | +2250.0% | 5,390 | +702.1% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 672 | +30.2% | 0.00% | – |
| Q4 2019 | $3,000 | +200.0% | 516 | +437.5% | 0.00% | – |
| Q3 2018 | $1,000 | -87.5% | 96 | -78.1% | 0.00% | -100.0% |
| Q4 2017 | $8,000 | +14.3% | 438 | +41.7% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +40.0% | 309 | -41.8% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 531 | -35.6% | 0.00% | – |
| Q1 2017 | $5,000 | -77.3% | 824 | -85.2% | 0.00% | -100.0% |
| Q4 2016 | $22,000 | -79.4% | 5,570 | -24.0% | 0.00% | -80.0% |
| Q2 2016 | $107,000 | – | 7,331 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |